Felix Beuschlein
#149,949
Most Influential Person Now
Endocrinologist
Felix Beuschlein's AcademicInfluence.com Rankings
Felix Beuschleinphilosophy Degrees
Philosophy
#8253
World Rank
#11595
Historical Rank
Logic
#5286
World Rank
#6673
Historical Rank

Download Badge
Philosophy
Felix Beuschlein's Degrees
- Doctorate Medicine University of Zurich
- PhD Endocrinology University of Zurich
Why Is Felix Beuschlein Influential?
(Suggest an Edit or Addition)Felix Beuschlein's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Immune Landscape of Cancer (2018) (2766)
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
- Evidence for two types of brown adipose tissue in humans (2013) (592)
- Integrated genomic characterization of adrenocortical carcinoma (2014) (519)
- Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
- Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. (2017) (473)
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
- Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension (2013) (464)
- Mutations in the deubiquitinase gene USP8 cause Cushing's disease (2014) (412)
- Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma (2009) (409)
- Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. (2014) (320)
- Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. (2016) (295)
- MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (284)
- Combination chemotherapy in advanced adrenocortical carcinoma. (2012) (275)
- High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. (2015) (272)
- Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. (2015) (244)
- Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism (2012) (242)
- Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. (2016) (241)
- Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma (2014) (240)
- Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. (2009) (239)
- Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry (2012) (211)
- High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. (2010) (207)
- Adrenal Venous Sampling: Evaluation of the German Conn's Registry (2011) (195)
- Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
- Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism (2017) (176)
- Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. (2009) (174)
- Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. (2015) (172)
- KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism (2012) (171)
- SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) (2015) (167)
- Risk factors associated with a low glomerular filtration rate in primary aldosteronism. (2009) (156)
- High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. (2009) (154)
- The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease. (2015) (149)
- Clinical review: Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review. (2013) (146)
- Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. (2006) (145)
- Clonal composition of human adrenocortical neoplasms. (1994) (138)
- Somatic ATP1A1, ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas (2014) (132)
- Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement. (2013) (130)
- The role of surgery in the management of recurrent adrenocortical carcinoma. (2013) (128)
- The ACE-2 in COVID-19: Foe or Friend? (2020) (120)
- Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas (2016) (116)
- ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences. (2015) (113)
- Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency. (2014) (112)
- Subclinical hypercortisolism: a state, a syndrome, or a disease? (2015) (109)
- Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism. (2016) (109)
- Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implications for tumorigenesis. (1997) (107)
- ACTH-receptor expression, regulation and role in adrenocortial tumor formation. (2001) (105)
- Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. (2012) (101)
- Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas (2017) (98)
- Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry. (2010) (97)
- Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites. (2018) (97)
- Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry. (2015) (96)
- Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: a systematic review of the literature. (2014) (95)
- Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatographytandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma (2013) (95)
- Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. (2002) (95)
- Biochemical diagnosis of phaeochromocytoma using plasma‐free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions (2014) (95)
- Growth analysis of the mouse adrenal gland from weaning to adulthood: time- and gender-dependent alterations of cell size and number in the cortical compartment. (2007) (94)
- Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine. (2007) (92)
- Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. (2012) (90)
- Ectopic pro-opiomelanocortin syndrome. (2002) (90)
- Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. (2011) (90)
- Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study. (2014) (89)
- Discerning malignancy in adrenocortical tumors: are molecular markers useful? (2001) (89)
- COVID-19 and metabolic disease: mechanisms and clinical management (2021) (88)
- Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. (2002) (88)
- Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma (2018) (87)
- Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism. (2014) (86)
- Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone. (2007) (86)
- Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study. (2019) (83)
- Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites. (2013) (82)
- Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma. (2000) (82)
- Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT. (2013) (82)
- CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma (2018) (80)
- Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. (2004) (79)
- Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study (2020) (79)
- Activin Induces x-Zone Apoptosis That Inhibits Luteinizing Hormone-Dependent Adrenocortical Tumor Formation in Inhibin-Deficient Mice (2003) (79)
- Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. (2013) (77)
- Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency. (2010) (76)
- Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease. (2014) (76)
- High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. (2003) (76)
- Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21‐hydroxylase deficiency than in patients with primary adrenal insufficiency (2011) (76)
- Life-threatening events in patients with pheochromocytoma. (2015) (75)
- Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism (2011) (75)
- Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation. (2005) (75)
- [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. (2008) (74)
- International histopathology consensus for unilateral primary aldosteronism. (2020) (74)
- Major Role of Cathepsin L for Producing the Peptide Hormones ACTH, β-Endorphin, and α-MSH, Illustrated by Protease Gene Knockout and Expression* (2008) (73)
- Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism (2018) (72)
- Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma (2017) (72)
- Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc expression (1997) (70)
- Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. (2010) (70)
- Adrenocortical carcinoma — towards genomics guided clinical care (2019) (70)
- A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome. (2015) (70)
- Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. (2012) (64)
- PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit (2014) (63)
- Screening for membrane hormone receptor expression in primary aldosteronism. (2009) (63)
- Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism. (2012) (63)
- Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits (2010) (62)
- Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology. (2015) (62)
- Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency. (2013) (62)
- Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study (2014) (60)
- Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. (2020) (59)
- Deficits in the management of patients with adrenocortical carcinoma in Germany. (2010) (58)
- Personalized Management of Pheochromocytoma and Paraganglioma (2021) (58)
- ACTH-dependent regulation of microRNA as endogenous modulators of glucocorticoid receptor expression in the adrenal gland. (2012) (58)
- Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation. (2016) (56)
- DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer. (2016) (56)
- Characterization of an adrenocorticotropin (ACTH) receptor promoter polymorphism leading to decreased adrenal responsiveness to ACTH. (2004) (55)
- Association of plasma aldosterone with the metabolic syndrome in two German populations. (2011) (55)
- The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry. (2009) (55)
- Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. (2006) (55)
- DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis. (1998) (55)
- Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. (2007) (55)
- Erratum: Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma (Cancer Cell (2016) 29(5) (723–736) (S153561081630160X) (10.1016/j.ccell.2016.04.002)) (2016) (54)
- Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome. (2018) (54)
- PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics. (2017) (53)
- Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas. (2014) (53)
- DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers (2015) (53)
- Contemporary microsurgical concept for the treatment of Cushing’s disease: endocrine outcome in 83 consecutive patients (2012) (52)
- Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors. (1998) (52)
- Persistence of myopathy in Cushing's syndrome: evaluation of the German Cushing's Registry. (2017) (51)
- Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms (2001) (51)
- Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex. (1998) (51)
- Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R. (2008) (51)
- Efficacy and acceptability of lanreotide Autogel® 120 mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR. (2010) (50)
- Adrenal cortical insufficiency--a life threatening illness with multiple etiologies. (2013) (50)
- Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma (2018) (50)
- H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series. (2014) (50)
- Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion. (2019) (49)
- Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetes (2007) (49)
- Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma (2018) (48)
- New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line (2000) (47)
- SF-1, DAX-1, AND ACD: MOLECULAR DETERMINANTS OF ADRENOCORTICAL GROWTH AND STEROIDOGENESIS (2002) (47)
- Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism (2018) (47)
- Silencing Mutated β-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R (2013) (46)
- Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone. (2012) (46)
- Timelines in the management of adrenal crisis – targets, limits and reality (2015) (46)
- Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3. (2016) (45)
- Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients (2018) (45)
- Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma (2019) (44)
- Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis. (2009) (44)
- Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas. (2015) (44)
- Somatic ATP 1 A 1 , ATP 2 B 3 , and KCNJ 5 Mutations in Aldosterone-Producing Adenomas (43)
- AKT is highly phosphorylated in pheochromocytomas but not in benign adrenocortical tumors. (2005) (43)
- Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma. (2019) (42)
- Time to diagnosis in Cushing's syndrome: A meta-analysis based on 5367 patients. (2020) (41)
- Sexual dimorphism in COVID-19: potential clinical and public health implications (2022) (40)
- An Update on Addison’s Disease (2018) (40)
- Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation (2016) (40)
- Pheochromocytoma and paraganglioma: Clinical feature based disease probability in relation to catecholamine biochemistry and reason for disease suspicion. (2019) (39)
- Gonadectomy in mice of the inbred strain CE/J induces proliferation of sub-capsular adrenal cells expressing gonadal marker genes. (2006) (39)
- Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine. (2019) (39)
- Pituicytoma in a patient with Cushing’s disease: case report and review of the literature (2012) (39)
- A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: validation in mouse serum. (2008) (38)
- Linear and volumetric evaluation of the adrenal gland--MDCT-based measurements of the adrenals. (2014) (38)
- Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor. (2018) (38)
- Steroidogenic acute regulatory protein mRNA expression in adrenal tumours. (2000) (37)
- Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma (2010) (37)
- Presence of brown adipocytes in retroperitoneal fat from patients with benign adrenal tumors: relationship with outdoor temperature. (2013) (36)
- Long-Term Outcome of Primary Bilateral Macronodular Adrenocortical Hyperplasia After Unilateral Adrenalectomy. (2019) (36)
- Regulation of aldosterone secretion: from physiology to disease (2013) (35)
- Expression and spatio-temporal distribution of differentiation and proliferation markers during mouse adrenal development. (2007) (35)
- Toward a Diagnostic Score in Cushing's Syndrome (2019) (35)
- Regulation of aldosterone secretion: from physiology to disease. (2013) (35)
- Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy (2018) (35)
- Aminoglutethimide suppresses adrenocorticotropin receptor expression in the NCI-h295 adrenocortical tumor cell line. (1998) (34)
- PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas. (2016) (33)
- Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. (2006) (32)
- CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease. (2009) (32)
- A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population. (2014) (31)
- cAMP signaling in cortisol-producing adrenal adenoma. (2015) (31)
- Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma (2017) (31)
- Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells (2013) (31)
- The SPARTACUS Trial: Controversies and Unresolved Issues (2017) (30)
- Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma (2019) (30)
- Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. (2020) (30)
- Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation (2021) (29)
- Consequences of the COVID-19 pandemic for patients with metabolic diseases (2021) (29)
- Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism (2020) (29)
- Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma (2015) (29)
- Molecular adrenocortical tumourigenesis (2000) (28)
- The Prevalence of Familial Hyperaldosteronism in Apparently Sporadic Primary Aldosteronism in Germany: a Single Center Experience (2012) (28)
- Cushing’s syndrome: a model for sarcopenic obesity (2017) (27)
- Intraoperative haemodynamic stability in patients with phaeochromocytoma – minimally invasive vs conventional open surgery (2006) (27)
- Cortisol Producing Adrenal Adenoma—a New Manifestation of Gardner's Syndrome (2000) (27)
- ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test. (2015) (27)
- Spontaneous remission of idiopathic aldosteronism after long‐term treatment with spironolactone: results from the German Conn’s Registry (2012) (27)
- Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism. (2015) (26)
- Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors (2022) (26)
- Levodopa therapy in Parkinson’s disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine (2014) (26)
- COVID-19 targets human adrenal glands (2021) (26)
- Plasma steroid profiles in subclinical compared to overt adrenal Cushing's syndrome. (2019) (26)
- Hair Glucocorticoids as a Biomarker for Endogenous Cushing’s Syndrome: Validation in Two Independent Cohorts (2019) (25)
- Histological characterization of aldosterone-producing adrenocortical adenomas with different somatic mutations. (2019) (25)
- ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo. (2005) (25)
- The role of regulated necrosis in endocrine diseases (2021) (24)
- Evaluation of a standardized protocol for processing adrenal tumor samples: preparation for a European adrenal tumor bank. (2010) (24)
- Fabry disease genotype, phenotype, and migalastat amenability: Insights from a national cohort (2019) (24)
- Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. (2000) (24)
- Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms. (2018) (23)
- Classification of microadenomas in patients with primary aldosteronism by steroid profiling (2019) (23)
- In situ metabolomics of aldosterone-producing adenomas. (2019) (23)
- Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model. (2014) (23)
- β-Catenin and FGFR2 regulate postnatal rosette-based adrenocortical morphogenesis (2020) (22)
- Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis. (2004) (22)
- Characterization of NCI-H295R Cells as an In Vitro Model of Hyperaldosteronism (2012) (22)
- ARMC 5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia : Clinical and Functional Consequences (2015) (22)
- Anti insulin-like growth factor I receptor immunoliposomes: a single formulation combining two anticancer treatments with enhanced therapeutic efficiency. (2010) (22)
- Current management and outcome of pregnancies in women with adrenal insufficiency: experience from a multi-center survey. (2020) (21)
- Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism - long-term outcome and clinical impact. (2019) (21)
- Low-dose glucose infusion after achieving critical hypoglycemia during insulin tolerance testing: effects on time of hypoglycemia, neuroendocrine stress response and patient's discomfort in a pilot study. (2005) (21)
- Isoenergetic Feeding of Low Carbohydrate-High Fat Diets Does Not Increase Brown Adipose Tissue Thermogenic Capacity in Rats (2012) (21)
- Association between 25-Hydroxyvitamin D Status and Components of Body Composition and Glucose Metabolism in Older Men and Women (2018) (21)
- Links between aldosterone excess and metabolic complications: A comprehensive review. (2020) (21)
- A microsphere-based duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: Validation in human and mouse plasma (2010) (21)
- The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance. (2018) (20)
- Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo (2018) (20)
- MANAGEMENT OF ENDOCRINE DISEASE: Fertility, pregnancy and lactation in women with adrenal insufficiency. (2018) (20)
- Metabolic Alterations in Patients with Pheochromocytoma (2018) (20)
- Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients. (2013) (20)
- HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas. (2020) (20)
- Therapeutic options after surgical failure in Cushing's disease: A critical review. (2019) (20)
- Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma. (2012) (20)
- Animal models of adrenocortical tumorigenesis (2012) (20)
- Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series (2017) (20)
- Stress-inducible-stem cells: a new view on endocrine, metabolic and mental disease? (2018) (19)
- Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas (2017) (19)
- Immunohistochemical expression of stem cell markers in pheochromocytomas/paragangliomas is associated with SDHx mutations. (2015) (19)
- Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up. (2018) (19)
- Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma. (2016) (19)
- Impact of 123 I-MIBG scintigraphy on clinical decision making in pheochromocytoma and paraganglioma. (2019) (19)
- Genetic influence of an ACTH receptor promoter polymorphism on adrenal androgen secretion. (2005) (19)
- Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches (2019) (19)
- RNA-Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights. (2020) (19)
- Proteomic Landscape of Aldosterone-Producing Adenoma (2019) (18)
- Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease (2021) (18)
- Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing's syndrome. (2017) (17)
- Aldosterone producing adrenal adenomas are characterized by activation of calcium/calmodulin-dependent protein kinase (CaMK) dependent pathways. (2011) (17)
- Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma (2020) (17)
- Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures. (2019) (17)
- The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2‐Year Follow‐Up Study (2020) (17)
- Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice. (2009) (17)
- KCNJ5 Mutations: Sex, Salt and Selection (2015) (17)
- TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors (2016) (16)
- The impact of Connshing's syndrome - mild cortisol excess in primary aldosteronism drives diabetes risk. (2017) (16)
- Role of bone morphogenetic proteins in adrenal physiology and disease. (2010) (16)
- Tumor size of Conn's adenoma and comorbidities. (2009) (16)
- Worsening of lipid metabolism after successful treatment of primary aldosteronism (2015) (16)
- Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma. (2014) (16)
- The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism (2016) (16)
- Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism. (2019) (16)
- Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma. (2020) (16)
- ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas. (2018) (15)
- Advances in adrenal tumors 2018 (2018) (15)
- Expression and mutational status of USP8 in tumors causing ectopic ACTH secretion syndrome. (2017) (15)
- Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas (2020) (15)
- Performance of LC–MS/MS and immunoassay based 24-h urine free cortisol in the diagnosis of Cushing's syndrome (2019) (15)
- Persisting Muscle Dysfunction in Cushing’s Syndrome Despite Biochemical Remission (2020) (14)
- Diastrophic Dysplasia Sulfate Transporter (SLC26A2) Is Expressed in the Adrenal Cortex and Regulates Aldosterone Secretion (2014) (14)
- The TALE homeodomain of PBX1 is involved in human primary testis‐determination (2019) (14)
- THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism. (2019) (14)
- Primary adrenal lymphoma: 3 case reports with different outcomes. (2011) (14)
- Adrenal Incidentalomas: Presentation and Clinical Work-Up (2007) (14)
- Steroidogenic acute regulatory (StAR)-directed immunotherapy protects against tumor growth of StAR-expressing Sp2-0 cells in a rodent adrenocortical carcinoma model. (2004) (14)
- Intracranial germinoma as a very rare cause of panhypopituitarism in a 23-year old man. (2008) (14)
- The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression - Lessons from primary aldosteronism. (2020) (14)
- Sepsis and cardiomyopathy as rare clinical manifestations of pheochromocytoma--two case report studies. (2010) (14)
- Aged PROP1 Deficient Dwarf Mice Maintain ACTH Production (2011) (14)
- Adrenal venous sampling guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT). (2020) (13)
- Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo — challenges and prospects (2015) (13)
- Metabolic impact of pheochromocytoma/paraganglioma: Targeted metabolomics in patients before and after tumor removal. (2019) (13)
- Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma (2015) (13)
- Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism (2018) (13)
- Targeting CXCR 4 ( CXC Chemokine Receptor Type 4 ) for Molecular Imaging of Aldosterone-Producing Adenoma (13)
- Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus in the Russian population. (1997) (13)
- Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits (2010) (12)
- Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension (2020) (12)
- Identification of adrenal genes regulated in a potassium-dependent manner. (2010) (12)
- Clinical and molecular evidence for DAX-1 inhibition of steroidogenic factor-1-dependent ACTH receptor gene expression. (2005) (12)
- Primary and Secondary Hyperparathyroidism in Patients with Primary Aldosteronism - Findings From the German Conn's Registry. (2019) (12)
- Xenograft models for adrenocortical carcinoma (2016) (12)
- Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours (2019) (12)
- Progress in Primary Aldosteronism (2010) (12)
- Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry. (2018) (12)
- Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma (2019) (12)
- Targeted Metabolomics as a Tool in Discriminating Endocrine From Primary Hypertension (2020) (12)
- Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxiety. (2021) (11)
- Genetics of adrenocortical tumours (2016) (11)
- IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma (2016) (11)
- Patients With Primary Aldosteronism Respond to Unilateral Adrenalectomy With Long-Term Reduction in Salt Intake (2019) (11)
- Is there a role for the adrenal glands in long COVID? (2022) (11)
- Prognostic value of histological markers in localized adrenocortical carcinoma after complete resection (2013) (11)
- Primary Aldosteronism. (2019) (11)
- Endocrine responses during CPAP withdrawal in obstructive sleep apnoea: data from two randomised controlled trials (2019) (11)
- Hypokalemia and the Prevalence of Primary Aldosteronism (2020) (11)
- Adrenocortical Tumorigenesis (2006) (11)
- Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma (2021) (10)
- Changes in Body Mass Index in Pheochromocytoma Patients Following Adrenalectomy (2017) (10)
- Spontaneous cerebrospinal fluid rhinorrhea in untreated macroprolactinoma--an indication for primary surgical therapy. (2006) (10)
- A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing’s syndrome (2019) (10)
- Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies. (2020) (10)
- Beyond a Disease Registry: An Integrated Virtual Environment for Adrenal Cancer Research (2016) (10)
- Perioperative Management of Endocrine Active Adrenal Tumors (2018) (10)
- PBX1 is dispensable for neural commitment of RA-treated murine ES cells (2009) (10)
- PRKACA Mutations in Adrenal Adenomas: Genotype/Phenotype Correlations (2016) (10)
- Gender-, strain-, and inheritance-dependent variation in aldosterone secretion in mice. (2012) (10)
- What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question (2021) (10)
- Missed clinical clues in patients with pheochromocytoma/paraganglioma discovered by imaging (2018) (9)
- ENSAT Registry-Based Randomized Clinical Trials for Adrenocortical Carcinoma. (2020) (9)
- Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients (2021) (9)
- Circulating microRNA Expression in Cushing’s Syndrome (2021) (9)
- The role of the ACTH receptor in adrenal tumors: identification of a novel microsatellite marker. (2004) (9)
- Daily adjustment of glucocorticoids by patients with adrenal insufficiency (2019) (9)
- 567O First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): An academic double-blind trial investigating sunitinib (2021) (9)
- Mc2 Receptor Knockdown Modulates Differentiation and Lipid Composition in Adipocytes (2012) (9)
- Volumetric and densitometric evaluation of the adrenal glands in patients with primary aldosteronism (2017) (9)
- Primärer Hyperaldosteronismus – Diagnostik und Therapie (2012) (9)
- The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy (2021) (9)
- Clinical Spectrum of Primary Adrenal Lymphoma: Results of a Multicenter Cohort Study. (2020) (9)
- Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper‐responsiveness of hypothalamo–pituitary–adrenal axis in patients with adrenal incidentalomas (2000) (8)
- Regulation of human MC2-R gene expression by CREB, CREM, and ICER in the adrenocortical cell line Y1. (2007) (8)
- Safety of medical adjustment and confirmatory testing in the diagnostic workup of primary aldosteronism. (2019) (8)
- Genetic and Potential Autoimmune Triggers of Primary Aldosteronism (2015) (8)
- Novel genes in primary aldosteronism (2014) (8)
- Genetik und Pathophysiologie der Adipositas (2006) (8)
- Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy? (2005) (8)
- Utilization of a mutagenesis screen to generate mouse models of hyperaldosteronism. (2011) (7)
- The Adrenal Gland: Central Relay in Health and Disease (2019) (7)
- Sleep quality in patients with primary aldosteronism. (2013) (7)
- Decreased p44/42 mitogen-activated protein kinase phosphorylation in gender- or hormone-related but not during age-related adrenal gland growth in mice. (2009) (7)
- Update endokrine Hypertonie (2018) (7)
- Diagnosis: Novel molecular signatures for adrenocortical carcinoma (2009) (7)
- Plasma steroid profiling in patients with adrenal incidentaloma. (2021) (6)
- Targeting Pheochromocytoma/Paraganglioma with polyamine inhibitors. (2020) (6)
- BEX1 Is Differentially Expressed in Aldosterone-Producing Adenomas and Protects Human Adrenocortical Cells From Ferroptosis (2021) (6)
- Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study (2022) (6)
- The natural history of adrenal incidentaloma - results from the international prospective multi-centre EURINE-ACT study (2017) (6)
- Altered Taste Perception for Sodium Chloride in Patients With Primary Aldosteronism (2021) (6)
- Patients with low IGF-I after curative surgery for Cushing's syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy. (2021) (6)
- Silencing Mutated b-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H 295 R (2013) (6)
- Mouse models of adrenal tumorigenesis. (2010) (6)
- CBP / p 300-Interacting Transactivator , with Glu / Asp-Rich C-Terminal Domain , 2 , and Pre-B-Cell Leukemia Transcription Factor 1 in Human Adrenal Development and Disease (2009) (6)
- Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells. (2017) (6)
- Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited (2022) (6)
- Establishment of an in vivo model for KCNJ5 dependent hyperaldosteronism (2015) (6)
- Referenz Endokrinologie und Diabetologie (2020) (6)
- The tumor stem cell concept—Implications for endocrine tumors? (2009) (6)
- The ubiquitin-specific peptidase 8 (USP8) gene is frequently mutated in adenomas causing Cushing's disease. (2015) (6)
- Mechanistic Roles of Inhibin as a Tumor Suppressor in the Adrenal Cortex (2004) (5)
- [Therapy-resistant hypertension--the endocrinological view]. (2007) (5)
- Identification of risk loci for primary aldosteronism in genome-wide association studies (2022) (5)
- Coexisting Prolactinoma and Primary Aldosteronism: Is There a Pathophysiological Link? (2015) (5)
- Identification of glucocorticoid-related molecular signature by whole blood methylome analysis (2021) (5)
- Biochemical diagnosis of pheochromocytoma using plasma free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions (2013) (5)
- Progress in Primary Aldosteronism: Translation on the Move (2015) (5)
- Urocortin-dependent effects on adrenal morphology, growth, and expression of steroidogenic enzymes in vivo. (2012) (5)
- Animal models of primary aldosteronism. (2010) (4)
- Adrenal and Ovarian Phenotype of a Tissue-Specific Urocortin 2-Overexpressing Mouse Model. (2015) (4)
- Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism (2019) (4)
- Clinical Impact of Recent Advances in the Biology of Adrenocortical Cancer (2003) (4)
- Multicenter case series of primary adrenal lymphoma (2016) (4)
- First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study. (2022) (4)
- Impact of surgery on clinical outcome in patients with recurrence of adrenocortical carcinoma (2009) (4)
- Virilization of a Young Girl Caused by Concomitant Ectopic and Intra-Adrenal Adenomas of the Adrenal Cortex (2013) (4)
- Cytotoxic T-cell response against steroidogenic acute regulatory protein using DNA vaccination followed by vaccinia virus infection in a mouse adrenal carcinoma model. (2004) (4)
- Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma. (2022) (4)
- Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion (2021) (4)
- Genetic characterization of a mouse line with primary aldosteronism. (2017) (4)
- Treatment of Primary Aldosteronism with mTORC1 Inhibitors. (2019) (4)
- Whole blood methylome-derived features to discriminate endocrine hypertension (2022) (3)
- Tinnitus With Unexpected Spanish Roots: Head and Neck Paragangliomas Caused by SDHAF2 Mutation (2019) (3)
- Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis. (2023) (3)
- Progress in Primary Aldosteronism 2019: New Players on the Block? (2020) (3)
- The adrenal X-zone is involved in progesterone inactivation (2006) (3)
- Adrenal crisis and general morbidity in chronic adrenal insufficiency prospectively assessed in 472 patients (2011) (3)
- Connshing syndrome - myth or reality? (2018) (3)
- Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors. (2018) (3)
- [Arterial hypertension and subclinical Cushing's syndrome]. (2010) (3)
- The Diagnosis and Treatment of Primary Hyperaldosteronism in Germany (2009) (3)
- Diagnostik einer endokrinenHypertonie: Wann screenen, und mit welchem Test? (2011) (3)
- Mass Spectrometry Imaging Identifies Metabolic Patterns Associated with Malignant Potential in Pheochromocytoma and Paraganglioma. (2021) (3)
- Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures. (2022) (3)
- Adrenal Gland Function and Dysfunction During COVID-19. (2022) (3)
- Sleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression. (2019) (3)
- Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism: Results of the Else Kröner-Fresenius Hyperaldosteronismus Registry (2014) (3)
- [Primary hyperaldosteronism: boundaries of diagnostics and therapy]. (2014) (3)
- Urine steroid metabolomics as a diagnostic tool in primary aldosteroinism (2015) (3)
- Inzidentalom und subklinische Funktionsstörungen der Nebenniere (2013) (3)
- Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial (2022) (3)
- Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin (2022) (3)
- The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients (2022) (3)
- [Diagnosis of endocrinological hypertension: when to screen, and by which method?]. (2011) (2)
- Frequency and causes of adrenal crises over life-time in patients with 21-hydroxylase deficiency (2012) (2)
- [Incidentaloma and subclinical disorders of the adrenal gland]. (2013) (2)
- Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma (2021) (2)
- Isolation of the side population (SP) from murine adrenal glands renders cells with adrenocortical stem cell properties (2007) (2)
- Influence of cortisol cosecretion on non-ACTH stimulated adrenal venous sampling in primary aldosteronism: a retrospective cohort study. (2022) (2)
- Investigating the Role of Cholesterol and Lipid Trafficking in Mitotane Resistance in Adrenocortical Carcinoma (2021) (2)
- The side population phenomenon enriches for designated adrenocortical progenitor cells in mice. (2012) (2)
- P-64 Decreased p44/42 MAPK phosphorylation in gender- or hormone-related but not during age-related adrenal gland growth in mice (2008) (2)
- Somatic PRKACA mutations: association with transition from pituitary-dependent to adrenal-dependent Cushing's syndrome. (2019) (2)
- Constitutive activation of PRKACA in adrenal Cushing's syndrome (2014) (2)
- Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension (2022) (2)
- Results of the ADIUVO trial, the first randomized study on post-operative adjuvant mitotane in patients with adrenocortical carcinoma (2021) (2)
- Predicting Hypertension Subtypes with Machine Learning Using Targeted Metabolites and Their Ratios (2022) (2)
- Adipositas – Klinische Bedeutung und Behandlungsstrategien (2011) (2)
- Favorable long-term outcome of bilateral adrenalectomy in Cushing's disease (2014) (2)
- Schon ein BMI von 25 sollte behandelt werden (2006) (2)
- Somatic RET mutation in a patient with pigmented adrenal pheochromocytoma (2016) (2)
- Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma (2018) (2)
- Primary aldosteronism: Diagnosis and differential diagnosis / Primärer Hyperaldosteronismus: Diagnose und Differentialdiagnose (2004) (2)
- Targeted therapies in Pheochromocytoma and Paraganglioma. (2022) (2)
- Urine steroid metabolomics is a highly sensitive tool for post-operative recurrence detection in adrenocortical carcinoma (2016) (2)
- Endocrine responses during CPAP-withdrawal in obstructive sleep apnea: data from two randomised controlled trials (2019) (2)
- cohort of 201 pheochromocytoma (2009) (2)
- Adrenal tumours and hormone excess. Editorial. (2009) (1)
- The German Conn's registry: comorbidities in over 700 patients with primary hyperaldosteronism (2008) (1)
- [The basics of lysosomal storage diseases]. (2018) (1)
- Pheochromocytoma/Paraganglioma is Associated with SDHx-mutations (2015) (1)
- Expression and distribution of differentiation and proliferation markers during mouse adrenal development (2005) (1)
- Neue Leitlinien zur Adipositas-Therapie : Schon ein BM1 von 25 sollte behandelt werden (2006) (1)
- Supplementary data from:Adrenal venous sampling (AVS) in Primary Bilateral Macronodular Adrenocortical Hyperplasia (PBMAH): A study of 16 patients (2021) (1)
- Mikro- und makronoduläre ACTH- unabhängige Nebennieren-Hyperplasie (2010) (1)
- [Thyroid nodules--Indication for surgery?]. (2016) (1)
- Progress in Primary Aldosteronism 2 (2012) (1)
- Peroxisome proliferator activated receptor gamma (PPARγ) agonists suppress adrenocortical tumor cell proliferation and induce differentiation (2005) (1)
- Die Grundlagen der lysosomalen Speicherkrankheiten (2018) (1)
- CITED2 and PBX1 in human adrenal development and disease (2009) (1)
- Prognostic value of DNA methylation in adrenocortical carcinomas: an ENSAT study (2014) (1)
- Interdisziplinäres Management von Patienten mit malignem Phäochromozytom (2013) (1)
- The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects. (2022) (1)
- Gonadectomized mice of the inbred strain CE/J develop adrenocortical tumors derived from subcapsular cells expressing x-zone marker (2004) (1)
- Predicitve Value of FDG Uptake in the Remaining Adrenal Gland Following Adrenalectomy for Adrenocortical Cancer (2020) (1)
- Prognostic factors of overall survival of stage III or IV adrenocortical carcinomas (ACC): A multicenter ENS@T study. (2014) (1)
- Animal Models of Adrenal Genetic Disorders (2014) (1)
- Anti-tumor activity of the tumor-vascular-disrupting agent ASA404 (vadimezan) in endocrine tumor models (2010) (1)
- Preanalytical Pitfalls in Untargeted Plasma Nuclear Magnetic Resonance Metabolomics of Endocrine Hypertension (2022) (1)
- Secondary causes of hypertension (2018) (1)
- European Network for the Study of Adrenal Tumors: Adrenal Cancer Consortium (ENS@T-CANCER) (2011) (1)
- Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study (2023) (1)
- [Genetics and pathophysiology of obesity]. (2006) (1)
- Development of a novel anti-IGF1 receptor immunoliposomal cancer therapy with enhanced therapeutic efficiency (2009) (1)
- Mitotane Targets Lipid Droplets to Induce Lipolysis in Adrenocortical Carcinoma (2022) (1)
- Characteristics of preoperative steroid profiles and glucose metabolism in patients with primary aldosteronism developing adrenal insufficiency after adrenalectomy (2021) (1)
- Nebennierenrindeninsuffizienz: Diagnostik und Therapie (1999) (1)
- PRKACA somatic mutations are rare in aldosterone-producing adenomas. (2016) (1)
- Sleep quality in patients with primary aldosteronism (2014) (1)
- Mild autonomous cortisol excess in adrenal incidentalomas - metabolic disease burden and urinary steroid metabolome in 1201 prospectively recruited patients (2017) (1)
- [Every eighth case of hypertension originates in the adrenal gland. For whom is it worthwhile to screen for an endocrine cause?]. (2010) (1)
- [Fabry disease - the profile of an orphan disease]. (2018) (1)
- Signs, symptoms and biochemistry in recurrent Cushing disease: a prospective pilot study (2021) (1)
- [ 123 I]Iodometomidate as a radiotracer for adrenal scintigraphy first clinical experience (2007) (1)
- Abstract 2976: Comprehensive Pan-Genomic characterization of adrenocortical carcinoma (2015) (1)
- SARS-CoV-2 infection and its effects on the endocrine system (2023) (1)
- Time from symptoms to diagnosis in Cushing's syndrome: results of the German Cushing Registry in Munich (2014) (1)
- The –2 basepair initiation start site ACTH receptor polymorphism influences ACTH induced adrenal androgen secretion (2005) (0)
- Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma (2023) (0)
- Review: A critical re-appraisal of bilateral adrenalectomy for ACTH- (2015) (0)
- Triple CFTR modulator therapy is associated with improved endocrine pancreatic function in patients with cystic fibrosis (2022) (0)
- Investigation of novel chemotherapeutic combinations in a tumor model of adrenocortical carcinoma (2013) (0)
- SUN-LB97 Targeted Metabolomics as a Screening Tool in the Diagnosis of Endocrine Hypertension (2020) (0)
- PRKACA mutations in adrenal Cushing impair association with the PKA regulatory subunit (2016) (0)
- Deoxyguanosine kinase mutation F180S is associated with a lean phenotype in mice (2023) (0)
- Remission, recurrence and control rates in patients with ACTH-dependent Cushing's syndrome- a monocentric, retrospective analysis (2016) (0)
- Urinary steroid profiling demonstrates induction of CYP3A4 and inhibition of 5alpha-reductase by mitotane treatment for adrenocortical carcinoma (2012) (0)
- Identification of a molecular signature of hypercortisolism by whole blood methylome analysis (2019) (0)
- Acknowledgement to referees (2006) (0)
- Repeated immunoliposomal treatment of endocrine tumors (2015) (0)
- [Obesity 2006]. (2006) (0)
- MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors (2020) (0)
- Treatment of refractory adrenocortical carcinoma with thalidomide: results of a retrospective analysis of 15 patients (2014) (0)
- Investigation of novel chemotherapeutic combinations in a tumor model for adrenocortical carcinoma (2013) (0)
- Moderators of the psychotropic effect of aldosterone in primary aldosteronism (2019) (0)
- Primary aldosteronism and the occurrence of hyperparathyroidism in the German Conn's registry (2015) (0)
- Human Cancer Biology MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (0)
- P-39 ANALYSIS OF THE IGF-SYSTEM AND GH/IGF-DEPENDENT SIGNALING CASCADES DURING GROWTH AND DEVELOPMENT OF THE ADRENAL GLAND (2006) (0)
- University of Birmingham Constitutive activation of PKA catalytic subunit in Adrenal Cushing's Syndrome (2014) (0)
- RF21 | PSAT77 ROLE OF THE TRANSCRIPTION FACTOR HHEX IN INNER ADRENAL CORTEX HOMEOSTASIS AND RESPONSE TO PROGESTERONE SIGNALING (2022) (0)
- Editorial: The adrenal gland: central relay in health and disease (2019) (0)
- Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells (2017) (0)
- Acknowledgement to Reviewers (2009) (0)
- The epoxyeicosatrienoic pathway is intact in endothelial and smooth muscle cells exposed to aldosterone excess (2021) (0)
- Arterial Hypertension (2021) (0)
- Muscle strength in Cushing's syndrome: cross-sectional evaluation of the German Cushing's registry (2016) (0)
- Cardiometabolic disease burden and urine steroid metabolome in benign adrenocortical tumours: a case-control study (2021) (0)
- Recurrent somatic mutations in Ying Yang 1 (YY1) are found in a subgroup of sporadic insulinomas (2015) (0)
- SUN-381 Somatic PRKACA Mutations In Patients With Transition From Pituitary-dependent To Adrenal-dependent Cushing’S Syndrome (2019) (0)
- tandem mass spectrometry : utility for diagnosis of dopamine-producing metastatic − chromatography Analysis of plasma 3-methoxytyramine , normetanephrine and metanephrine by ultraperformance liquid (2013) (0)
- Health-Related Quality of Life in Fabry Disease: A Cross-sectional International Multicenter Study (2021) (0)
- Results of transsphenoidal surgery for Cushing's disease in a contemporary series (2006) (0)
- Differential expression of protein kinase A catalytic and regulatory subunits in adrenocortical adenomas (2016) (0)
- Armadillo repeat containing 5 gene (ARMC5) alterations in a large cohort of 98 ACTH-independant macronodular adrenal hyperplasia (AIMAH) patients: genotype/phenotype correlations. (2014) (0)
- Incidence of Primary Aldosteronism in Patients with Hypokalemia (IPAHK+): Study Design and Baseline Characteristics (2021) (0)
- Identification of clinical parameters predictive of ARMC5 mutation in a large cohort of primary bilateral macronodular adrenal hyperplasia (PBMAH) patients. (2020) (0)
- Targeted molecular markers derived from genomic classification for adrenocortical cancer prognostication (2017) (0)
- BMP dependent effects on adrenal tumorigenesis and function (2007) (0)
- Differential TNF[alpha] -synthesis and signaling in endocrine tumors after treatment with the Tumor-Vascular-Disrupting Agent ASA404 (vadimezan) (2012) (0)
- Differential expression of the PKA subunits in adrenocortical adenomas (2015) (0)
- Life-threatening emergencies in patients with pheochromocytoma (2013) (0)
- Associations of different hormonal contraceptive methods with hair concentrations of cortisol, cortisone, and testosterone in young women (2022) (0)
- Expression of prolactin receptor in aldosterone-producing adrenal adenomas (2014) (0)
- COVID-19 in Fabry disease: a reference center prospective study (2022) (0)
- Outcome of patients with adrenocortical cancer after discontinuation of adjuvant mitotane therapy (2017) (0)
- Investigation of a novel liposomal chemotherapy protocol in three preclinical models for adrenocortical carcinoma in vivo (2015) (0)
- [Adrenal cortex insufficiency: diagnosis and therapy]. (1999) (0)
- Management of adrenal crisis – targets, limits and realities (2014) (0)
- k G, Reincke zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. (1970) (0)
- Site specific overexpression of urocortin 2 results in modulation of steroidogenesis in vivo (2011) (0)
- Calcineurin-NFATc4 Pathway Is Activated Upon K+-stimulation of Adrenal Aldosterone Production (2021) (0)
- DIFFERENTIAL DIAGNOSIS OF PRIMARY ALDOSTERONISM SUBTYPES USING ADRENAL VEIN SAMPLING: EVALUATION OF THE GERMANS CONNʼS REGISTRY: 4D.07: (2010) (0)
- Development and characterisation of patient-individual tumor models for endocrine tumors (2011) (0)
- Early post-operative ACTH-stimulated aldosterone predicts long-term biochemical outcome in primary aldosteronism (2022) (0)
- BMP dependent modulation of adrenocortical growth and function (2008) (0)
- [Autonomous cortisol secretion : Laboratory artifact or disease?] (2021) (0)
- Screening for peptide hormone receptor expression in primary aldosteronism (2007) (0)
- [123I]Iodometomidate as a radiotracer for adrenal scintigraphy – first in vivo experience (2007) (0)
- Female patients with primary aldosteronism are diagnosed earlier and have a better cardiovascular outcome after treatment (2013) (0)
- The endocrine society practice guideline revisited: why do nowadays patients undergo screening for cushing' syndrome, and with which outcome? (2022) (0)
- Immunophenotypic differences in patients with primary adrenal insufficiency of different etiology (2023) (0)
- Circular RNA-based biomarkers in blood of patients with Fabry disease and related phenotypes (2021) (0)
- Acknowledgment of Reviewers, 2019 (2019) (0)
- Plasma metabolomics profile in patients with Cushing's syndrome (2016) (0)
- New germline mutation in CACNA1H calcium channel causing primary aldosteronism (2016) (0)
- Mc2 receptor in adipocytes is significant for lipid composition and regular lipolysis (2009) (0)
- Towards an aldosterone producing cell line from an aldosterone producing adenoma (2009) (0)
- Female patients with primary aldosteronism are diagnosed earlier and have a better outcome (2012) (0)
- Dopamine agonist-responsive Cushing’s disease (2019) (0)
- Abstract 4059: The bone morphogenic protein 7 (Bmp7) plays a pro-tumorigenic role in pheochromocytoma (2014) (0)
- Clinical and biochemical outcome after unilateral adrenalectomy in primary aldosteronism (2015) (0)
- Demographics of adrenal incidentaloma - results from an international prospective multi-centre study in 2190 patients (2016) (0)
- Protein Kinase A signaling saves regulatory subunit II[beta] from PRKACA mutation-mediated degradation (2017) (0)
- Identification of genes mediating dysregulated cell growth in aldosterone-producing adenomas (2019) (0)
- MUC-1: update on a newly established tumor model for adrenocortical carcinoma (2016) (0)
- Mass spectrometry-based adrenal venous steroid profiling for subtyping primary aldosteronism (0)
- Differential TNF[alpha] and Toll-like-receptor 4-signaling in endocrine tumors after tumor- vascular- disrupting Agent ASA404 (Vadimezan) and TNF[alpha] treatment (2014) (0)
- MicroRNAs as endogenous modulators of glucocorticoid receptor expression in the adrenal gland after ACTH stimulation test (2011) (0)
- Molecular pathogenesis of adrenocortical tumors (2009) (0)
- Management and outcome of pregnancies in women with adrenal insufficiency: experience from a retrospective European study (2019) (0)
- University of Birmingham Somatic PRKACA mutations Birmingham portal (2019) (0)
- The influence of surgery in the management of recurrent adrenocortical carcinoma. (2012) (0)
- Adrenale Hypertonieformen Von der Diagnose zur Therapie (2006) (0)
- Ektope Hormonsekretion bei neuroendokrinen Tumoren Schwerpunktherausgeber (2012) (0)
- Morbus Gaucher – ein Überblick über eine Sphingolipidose (2018) (0)
- Ab wann muss eine Schilddrüsenüberfunktion behandelt werden? (2008) (0)
- Therapiealgorithmus bei Patienten mit malignem Phäochromozytom (2013) (0)
- Therapieresistente Hypertonien sind häufig hormonbedingt (2007) (0)
- CME-Antworten : zu den Fragen zu «Rationale Abklärungsstrategie bei einem Nebenniereninzidentalom» aus Praxis Nr. 19 (2017) (0)
- Endokrinologie und Diabetologie: Primärer Hyperaldosteronismus – was können wir besser machen? (2017) (0)
- Kapitel 2 – Endokrinologie (2013) (0)
- Intrakranielle Hypertension – und was macht der Blutdruck? (2020) (0)
- Morbus Fabry – das Porträt einer seltenen Erkrankung (2018) (0)
- Diagnostik und Therapie endokriner Hochdruckformen – Primärer Hyperaldosteronismus, Hyperkortisolismus und Katecholaminexzess (2009) (0)
- Schilddrüsenknoten: wann operieren? (2016) (0)
- Primärer Hyperaldosteronismus – wo liegen die Grenzen der Diagnostik und Therapie? (2014) (0)
- KAPITEL 17 – Endokrine Erkrankungen (2009) (0)
- Korrelation zwischen Nebennierenmorphologie und kardiovaskulären Parametern (2015) (0)
- Primärer Hyperaldosteronismus und Hypokaliämie (2021) (0)
- Knochenumbaumarker bei Cushing-Patienten im longitudinalen Verlauf (2020) (0)
- Das Cushing-Syndrom: Diagnostik und Therapie (1999) (0)
- Häufigkeit und Ursachen von Nebennierenkrisen bei Patienten mit Adrenogenitalem Syndrom (2014) (0)
- Endokrine Probleme nach allogener hämatologischer Stammzelltransplantation (2001) (0)
- Bei wem lohnt das Screening auf eine endokrine Ursache? (2010) (0)
- Inzidentalom und subklinische Funktionsstörungen der Nebenniere (2013) (0)
- CME: Rationale Abklärungsstrategie bei einem Nebenniereninzidentalom (2017) (0)
- Neuroendokrine Tumoren des gastroenteropankreatischen Systems (2012) (0)
- The Vault Complex Is Significantly Involved in Therapeutic Responsiveness of Endocrine Tumors and Linked to Autophagy under Chemotherapeutic Conditions (2023) (0)
- Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia (2023) (0)
- β-Catenin and FGFR2 regulate postnatal rosette-based adrenocortical morphogenesis (2020) (0)
- Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST” (Taper Or Abrupt Steroid STop) multicenter trial (2023) (0)
- Functional Implications of PRKACA Somatic Mutations (2017) (0)
- Diagnostic and therapeutic challenges in cyclic Cushing's syndrome: A systematic literature review (2023) (0)
- Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome. (2023) (0)
- Metastatic pheochromocytoma and paraganglioma: Somatostatin receptor 2 expression, genetics and therapeutic responses. (2023) (0)
- Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma (2023) (0)
- Pregnancy outcomes in women with classic and non-classic congenital adrenal hyperplasia (2023) (0)
- Poor adherence of patients with chronic adrenal insufficiency to medical advice in daily life (2015) (0)
- Triiodothyronine supplementation improves lipid parameters in central hypothyroidism: a randomized controlled trial ('4 T study') (2005) (0)
- Animal models of primary aldosteronism. (2009) (0)
- Increased risk of cardiometabolic disease in patients with benign adrenal tumours with and without cortisol excess: a casecontrol study (2021) (0)
- International multicenter survey on screening and confirmatory testing in primary aldosteronism. (2023) (0)
- PRKACA mutations in adrenal Cushing can alter substrate specificity (2017) (0)
- Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples – preparation for an international adrenal tumor bank (2006) (0)
- Immunoexpressions of CYP11B2 and HSD3B2 in genetically characterised aldosterone producing adenomas (2015) (0)
- Effectiveness of eplerenone or spironolactone treatment and adrenalectomy regarding renal function in male patients with primary aldosteronism (2011) (0)
- Anxiety and depressive symptoms in patients with primary aldosteronism in a longitudinal study (2012) (0)
- Assessment of VAV 2 expression refines prognostic prediction � . 3 in adrenocortical carcinoma � (0)
- The Role of Inhibin and Activin in Adrenal Tumorigenesis (2004) (0)
- Genomic approach to management of adrenal tumours (2017) (0)
- Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation. (2023) (0)
- Genetics of primary aldosteronism (2013) (0)
- Acknowledgement to Referees (2005) (0)
- RNA-sequencing of adrenocortical tumors reveals novel pathogenetic insights (2020) (0)
- OR29-2 Mild Autonomous Cortisol Excess (MACE) in Adrenal Incidentalomas - Metabolic Risk Profile and Urinary Steroid Metabolome Analysis in 1208 Prospectively Recruited Patients (2019) (0)
- PF311 ISOLATED PRIMARY ADRENAL LYMPHOMA (IPAL) - AN EMERGING LYMPHOMA ENTITY? RESULTS OF A RETROSPECTIVE MULTICENTER STUDY (2019) (0)
- Preoperative pegvisomant as a potential therapeutic option to improve cardiac function in Acromegaly-induced cardiomyopathy: Two cases (2020) (0)
- Reduced fertility rates and high prevalence of testicular adrenal rest tumors (TART) in male patients with congenital adrenal hyperplasia (2008) (0)
- P02-40 Anti-IGF1 receptor immunoliposomes: A single formulation combining two anticancer treatments with enhanced therapeutic efficiency (2012) (0)
- Establishment of patient-individual tumor models for endocrine tumors (2013) (0)
- Zona glomerulosa derived Klotho does not regulate aldosterone synthesis in young mice (2021) (0)
- Beyond a Disease Registry: An Integrated Virtual Environment for Adrenal Cancer Research (2016) (0)
- A role for vault particles as mediator for therapeutic effects against endocrine tumors (2015) (0)
- Cell cycle progression score as a predictive biomarker for overall survival in patients with adrenocortical carcinoma (2020) (0)
- Steroidogenic factor 1 - a valuable diagnostic and prognostic tool in patients with adrenocortical carcinoma (2009) (0)
- Comparison of strategies for biochemical diagnosis of primary aldosteronism in German academic centres (2008) (0)
- Characteristics of aldosterone-producing adenomas: a tissue microarray study (2017) (0)
- MUC-1 – a novel preclinical model for adrenocortical carcinoma? (2014) (0)
- Author response for "The effect of biochemical remission on bone metabolism in Cushing's syndrome: a two‐year follow‐up study" (2020) (0)
- Endocrine disorders in patients with Fabry Disease: A comprehensive reference center study (2021) (0)
- Identification d’une signature moléculaire d’hypercortisolisme par analyse du methylome du sang total (2020) (0)
- Long-term outcome of laparoscopic versus open adrenalectomy for adrenocortical carcinoma (2009) (0)
- Urine steroid metabolomics as a novel diagnostic tool for recurrent adrenocortical carcinoma detection (2019) (0)
- BMP5 treatment of adrenocortical carcinoma delays tumor growth via activation of endogenous anti-tumoral macrophages (2013) (0)
- Dose interval comparison of Lanreotide Autogel 120 mg in acromegalic patients previously treated with Octreotide LAR (2009) (0)
- Are Anxiety and Depression Mediated by Different Mineralocorticoid Receptor Pathways? Results From Primary Aldosteronism (2021) (0)
- Diagnosing Vasopressin Deficiency (Central Diabetes Insipidus) using Copeptin following Hypertonic Saline and Arginine Stimulation (2023) (0)
- Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples preparation for an European adrenal tumor bank (ENS@T) (2006) (0)
- [Obesity - clinical impact and therapeutic strategies]. (2011) (0)
- [Gaucher's disease - an overview about a sphingolipidosis]. (2018) (0)
- Response Letter to the Editor from Sweeney AT: "CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma". (2020) (0)
- Awareness & participation in rare disease registries within the European reference network on rare endocrine conditions (Endo-ERN) (2018) (0)
- methoxytyramine spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass (2013) (0)
- Hypercortisolism-related molecular signature: Results from whole blood methylome analysis (2020) (0)
- The epoxyeicosatrienoic pathway is intact in endothelial and smooth muscle 1 cells exposed to aldosterone excess 2 Short title : Intact EET pathway in hyperaldosteronism 3 (2021) (0)
- Primary aldosteronism – prevalence and prognosis in primary care (2014) (0)
- MUC-1 - a novel preclinical model for adrenocortical carcinoma (2014) (0)
- General morbidity and working capacity in patients with chronic adrenal insufficiency – A prospective study (2015) (0)
- Steroid and global metabolome in benign adrenal tumours with mild autonomous cortisol secretion: analysis by mass spectrometry and machine learning to understand metabolic risk (2022) (0)
- Clonal Composition of Human Adrenocortical Neoplasms 1 (2006) (0)
- Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism following adrenalectomy (2012) (0)
- Extensive preclinical screening of chemotherapeutic agents and molecular targeted Inhibitors reveals potent combinatory treatment for adrenocortical carcinoma (ACC) (2021) (0)
- OR34-02 Somatic Transmembrane Domain Mutations of a Cell Adhesion Molecule, CADM1, Cause Primary Aldosteronism by Preventing Gap Junction Communication Between Adrenocortical Cells (2019) (0)
- GLUCO- AND MINERALOCORTICOIDS SYNERGISTICALLY DOWNREGULATE BKCA CHANNEL TRANSCRIPTION IN VASCULAR SMOOTH MUSCLE CELLS BUT DO NOT AFFECT THE EPOXYEICOSATRIENOIC ACID PATHWAY (2021) (0)
- Canakinumabin patients with COVID-19 and type 2 diabetes (CanCovDia) - a multicentric, randomised, double-blind, placebo-controlled phase 3 trial (2022) (0)
- Low SLC26A2 expression in adrenal cells is associated with high aldosterone output (2012) (0)
- MON-380 Tinnitus with Unexpected Spanish Roots: Head and Neck Paragangliomas Caused by SDHAF2 Mutation (2019) (0)
- Influence of antihypertensive medication on the screening parameter aldosterone to renin ratio in patients with essential hypertension and primary aldosteronism (2014) (0)
- Liposome based strategies for the treatment of adrenocortical carcinoma (2011) (0)
- High levels of ACTH can restore adrenal morphology and function in POMC knock out mice (2005) (0)
- Novel Distributed Informatics Platform to Support Machine Learning Discovery of Metabolic Biomarkers in Hypoxia Predisposition (2023) (0)
- Acknowledgment to Reviewers (2020) (0)
- The national Conn's registry: Objectives and first results (2007) (0)
- First phase insulin secretion is impaired by aldosterone excess in primary aldosteronism (2013) (0)
- In Situ Metabolomics of Cortisol-Producing Adenomas. (2022) (0)
- Potassium channels in primary aldosteronism (2012) (0)
- Aldosterone Insufficiency Contributes to Calcineurin Inhibitor‐induced Hyperkalemia (2021) (0)
- 46,Xy Dsd Caused by a De Novo Missense Mutation in the Tale Homedomain of Pbx1 (2017) (0)
- Cardiovascular outcome in patients with primary aldosteronism following adrenalectomy and mineralocorticoid antagonist treatment: prospective results of the Munich Conn Center (2014) (0)
- Regulation of ACTH-R gene expression by CREB, CREMt and ICER in the adrenocortical cell line Y1 (2005) (0)
- ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas (0)
- Characterization of Stem Cell Markers in Pheochromocytomas and Paragangliomas (2014) (0)
- SAT-LB23 Paraneoplastic Hypercalcemia in a PTH Producing Adrenocortical Carcinoma - a Rare and Deadly Condition (2020) (0)
- Adrenal phenotype in TPIT insufficient animals cannot be restored by short-term treatment with physiological doses of ACTH and N-POMC (2005) (0)
- Subtype differentiation in primary hyperaldosteronism: evaluation of alternative algorithms avoiding a controversial gold standard (2010) (0)
- Endocrine disorders in patients with Fabry disease: insights from a reference centre prospective study (2021) (0)
- Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma. (2022) (0)
- Mechanisms and consequences of endocrine autonomy - lessons learned from the adrenal cortex (2019) (0)
- Obstructive sleep apnea in primary aldosteronism is associated with cortisol cosecretion (2020) (0)
- Role of GLUT-2 expression and MGMT methylation for streptozotocin clinical response in adrenocortical carcinoma (2018) (0)
- [Neuroendocrine tumors of the gastroenteropancreatic system. An interdisciplinary challenge]. (2012) (0)
- Machine Learning models for the accurate prediction of malignant pheochromocytomas and paragangliomas (2022) (0)
- Metabolic and inflammatory parameters for baseline characterization and treatment outcome of prolactinoma patients (2022) (0)
- Post saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism (2014) (0)
- ACTH receptor promoter polymorphism associated with a decrease in adrenal responsiveness to ACTH – in vitro and in vivo characterization (2004) (0)
- Characterization of transcriptional and miRNA based dysregulations in Cushing's syndrome (2021) (0)
- [123I]Iodometomidate as a radiotracer for diagnosis of adrenal tumours and adrenocortical carcinoma (2008) (0)
- Diurnal Salivary Cortisol Profiles in Patients with Cushing's Syndrome. (2022) (0)
- Somatic mutations in USP8 are frequent events in pituitary tumors causing Nelson's syndrome (2017) (0)
- Molecular classifiers refine the prognostic stratification of adrenocortical carcinoma (2018) (0)
- Role of KCNJ5 mutations in mediating cell growth in aldosterone-producing adenomas (2019) (0)
- Glucocorticoid production in primary aldosteronism - from mechanisms to clinical implications (2017) (0)
- Identification and stratification of pheochromocytomas/paragangliomas with SDHx mutations using the succinate to fumarate ratio (2014) (0)
- Establishment of a mutagenesis screen to identify mice with high aldosterone levels (2008) (0)
- [OP.3A.06] LONG TERM FOLLOW-UP IN PATIENTS OPERATED ON A PHEOCHROMOCYTOMA OR A PARAGANGLIOMA: COMPILATION OF THE ENS@T DATABASE (2016) (0)
- Reduction of steroid replacement therapy in patients with congenital adrenal hyperplasia in the transition period from child- to adulthood (2007) (0)
- Identification and characterization of the adrenal tumor side population (2007) (0)
- Differential TNFα and Toll-like-receptor 4-signaling in endocrine tumors after tumor-vascular-disrupting agent ASA404 (vadimezan) and TNFα treatment (2014) (0)
- Spatio-temporal expression of the ACTH receptor during mouse adrenal development: Implication for adrenal growth and differentiation (2004) (0)
- Expression and mutational status of USP8 in tumours causing ectopic Cushing's syndrome (2016) (0)
- Prevalence and clinical correlates of CACNA1D mutations in primary aldosteronism (2014) (0)
- Renal function in patients with primary aldosteronism: comparison with essential hypertension (2008) (0)
- Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials (2019) (0)
- CAV1.3, HSD3B2 and CYP11B2 immunoexpressions in aldosterone-producing adenoma are not correlated with post-adrenalectomy outcome in primary aldosteronism (2015) (0)
- Intact endothelial epoxyeicosatrienoic acids pathway in primary aldosteronism – the route to new treatment strategies? (2020) (0)
- Cardiovascular morbidity in patients with suspected Cushing's syndrome. A prospective evaluation of the German Cushing's registry (2015) (0)
- Urine steroid metabolomics as a novel diagnostic tool for early detection of recurrence in adrenocortical carcinoma (2015) (0)
- High-sensitive C-reactive protein in primary aldosteronism Reply (2017) (0)
- Urine steroid metabolome analysis allows for metabolic risk stratification in 1309 prospectively recruited patients with benign adrenal tumours and different degrees of cortisol excess (2019) (0)
- Targeting mutated [beta]-catenin in vitro and in vivo inhibits cell proliferation and stimulates apoptosis: a promising therapeutic target in adrenocortical carcinoma (2012) (0)
- [A common hormonal imbalance with a wide clinical spectrum. When must hyperthyroidism be treated?]. (2008) (0)
- Influence of somatic mutations on the lateralization index of adrenal vein sampling in aldosterone producing adenomas (2013) (0)
- n euroendocrine Tumor r ecurrence: Diagnosis with 68 Ga-DOTATATE PET/CT 1 (2014) (0)
- A functional polymorphism at the transcription initiation site of the ACTH receptor gene associated with lower responsiveness to ACTH (2007) (0)
- Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas (2017) (0)
- Prospective prediction of germ line mutations in patients with pheochromocytomas and paragangliomas according to biochemical profiles (2015) (0)
- Prolactinoma and primary aldosteronism: is there a causal link? (2015) (0)
- Time to diagnosis in Cushing’s syndrome: Impact of subtypes and gender (2019) (0)
- Advances in genetic causes of adrenal Cushing's (2015) (0)
- Smoc1, Mtus1 and Gpr48 are regulated in potassium dependent aldosterone secretion (2007) (0)
- Characterization of a mouse model with mutagenesis induced hyperaldosteronism (2009) (0)
- Focal DNA methylation measurement in adrenocortical carcinoma is a prognostic marker independent from tumor stage and Ki67; an ENSAT study (2016) (0)
- The European Journal of Endocrinology Prize Winner (2013) (0)
- Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients (2018) (0)
- Subject Index Vol. 68, Suppl. 5, 2007 (2007) (0)
- [Cushing syndrome: diagnosis and therapy]. (1999) (0)
- Is steroid profiling using LC-MS/MS useful in the diagnostic work-up of primary aldosteronism? (2016) (0)
- A mouse model with hyperaldosteronism carrying an ENU induced mutation on chromosome 9 (2010) (0)
- Autonome Kortisolsekretion (2021) (0)
- Update endokrine Hypertonie (2019) (0)
- Diagnosis and Treatment of Primary Aldosteronism in 2017: Did We Achieve Our Goals? (2017) (0)
- ACTH-Receptor-initiated Signaling in Adrenal Tumorigenesis (2004) (0)
- OR34-04 Efficiency of Adrenal Venous Sampling in the Treatment Choice of Primary Aldosteronism (AVSTAT Study) (2020) (0)
- Screening for aberrant peptide hormone responsiveness in primary aldosteronism (2008) (0)
- Deficits in the clinical management of patients with adrenocortical carcinoma in Germany (2008) (0)
- A role for vault particles as a marker for therapeutic effects against endocrine tumours (2015) (0)
- Eighteenth Conference on the Adrenal Cortex Munich, Germany June 25–27, 2018 (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Felix Beuschlein?
Felix Beuschlein is affiliated with the following schools: